Entac Medical

Entac Medical is a private, early-stage digital health company founded in 2018 and based in San Francisco. It is developing a proprietary technology platform, PrevisAI™, which analyzes biological acoustic signals via wearable devices to predict adverse clinical events like delirium. The company's strategy targets reducing hospital readmissions and care costs by shifting from reactive to proactive patient monitoring. Its leadership combines expertise in healthcare investing, predictive analytics/AI commercialization, clinical surgery, and medical device development.

PrevisAI™ platform: A wearable device and analytics system that uses audio spectral analysis and machine learning on biological acoustic signals to predict downstream patient adverse events.

Entac competes in the broader remote patient monitoring and predictive analytics space, which includes large players like Medtronic and Philips, as well as numerous startups focusing on AI-driven diagnostics. Its specific focus on biological acoustics for adverse event prediction is a differentiating niche, but it must demonstrate superior clinical utility to gain market share.